Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.2600 (4.16%) ($6.8700 - $7.3700) on Thu. Apr. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.58% (three month average) | RSI | 45 | Latest Price | $7.2600(4.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN advances 0.3% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(68%) XBI(66%) ARKK(64%) IBB(60%) IPO(56%) | Factors Impacting CGEN price | CGEN will decline at least -3.29% in a week (0% probabilities). VXX(-36%) VIXM(-31%) UUP(-18%) IGOV(-5%) TBT(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.29% (StdDev 6.58%) | Hourly BBV | 0 () | Intraday Trend | 5.7% | | | |
|
Resistance Level | $7.88 | 5 Day Moving Average | $7.25(0.14%) | 10 Day Moving Average | $7.11(2.11%) | 20 Day Moving Average | $7.88(-7.87%) | To recent high | -38.6% | To recent low | 25.4% | Market Cap | $600m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |